539206
GVBL
Start SIP
Invest Now
Start SIP in GVBL
Performance
- Low
- ₹26
- High
- ₹27
- 52 Week Low
- ₹20
- 52 Week High
- ₹71
- Open Price₹26
- Previous Close₹26
- Volume1,555
- 50 DMA₹26.04
- 100 DMA₹29.57
- 200 DMA₹37.00
Investment Returns
- Over 1 Month + 5.02%
- Over 3 Month -8.54%
- Over 6 Month -36.8%
- Over 1 Year -38.35%
Smart Investing Starts Here Start SIP with Genomic Valley Biotech for Steady Growth!
Genomic Valley Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -183.4
- PEG Ratio
- 1.6
- Market Cap Cr
- 8
- P/B Ratio
- 2.1
- Average True Range
- 2.28
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.1
- RSI
- 58.88
- MFI
- 41.24
Genomic Valley Biotech Financials
Genomic Valley Biotech Technicals
EMA & SMA
Current Price
₹26.98
+
0.98
(3.77%)
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹25.40
- 50 Day
- ₹26.04
- 100 Day
- ₹29.57
- 200 Day
- ₹37.00
Resistance and Support
26.65
- R3 28.29
- R2 27.63
- R1 27.31
- S1 26.33
- S2 25.67
- S3 25.35
Genomic Valley Biotech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-15 | Quarterly Results | |
| 2025-10-15 | Quarterly Results | |
| 2025-08-07 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-14 | Quarterly Results |
Genomic Valley Biotech F&O
About Genomic Valley Biotech
- NSE Symbol
- GVBL
- BSE Symbol
- 539206
- Managing Director
- Mr. Yogesh Agrawal
- ISIN
- INE574D01010
Similar Stocks to Genomic Valley Biotech
Genomic Valley Biotech FAQs
Genomic Valley Biotech share price is ₹26 As on 12 February, 2026 | 17:52
The Market Cap of Genomic Valley Biotech is ₹8.2 Cr As on 12 February, 2026 | 17:52
The P/E ratio of Genomic Valley Biotech is -183.4 As on 12 February, 2026 | 17:52
The PB ratio of Genomic Valley Biotech is 2.1 As on 12 February, 2026 | 17:52
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.